Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma
Jun 8, 2021
20:01
Episode Description
Dr Nastoupil and Dr Dreyling discuss PI3K inhibition in follicular lymphoma, including practical considerations and treatment selection.
Credit available for this activity expires: 6/7/2022
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952387?src=mkm_podcast_addon_952387
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows
